G Square Healthcare has announced that its portfolio company, Duomed Group, is contemplating a sale to Palex Medical, aiming to create a comprehensive pan-European platform for medical technology solutions.

Target Company Information

Duomed Group, headquartered in Belgium, is a prominent European distributor specializing in medical technologies. With over 50 years of industry experience, Duomed focuses on several critical domains, including endoscopy, surgery, critical care, medical imaging, physiology monitoring, and infection control. The company's established reputation is built on delivering high-quality services and innovative medical solutions across 17 therapeutic areas.

The planned transaction with Palex Medical aims to enhance Duomed's geographic reach and strengthen its product offerings. This collaboration would enable both companies to provide comprehensive medical solutions across Northern, Western, and Southern Europe, while preserving Duomed's local identity. The transaction follows Duomed's impressive growth trajectory and recent successful acquisitions, positioning it as a leading pan-European platform.

Industry Overview in Europe

The medical technology (MedTech) industry in Europe is rapidly evolving, driven by technological advancements and an increasing demand for innovative healthcare solutions. The region is home to a diverse range of healthcare providers and medic

View Source

Similar Deals

Tilleghem Aptco Group

2025

Strategic Partnership Advanced Medical Equipment & Technology (NEC) Belgium
Sobi ChondroCelect

2014

Strategic Partnership Bio Therapeutic Drugs Belgium
Darling Ingredients Inc. Tessenderlo Group

2026

Joint Venture Pharmaceuticals (NEC) Belgium
Boston Scientific Nalu Medical

2026

Strategic Partnership Medical Devices & Implants United States of America
VanRoey Group K

2025

Strategic Partnership IT Services & Consulting (NEC) Belgium
Barça Innovation Hub Omniscope

2025

Strategic Partnership Biotechnology & Medical Research (NEC) Spain

Palex Medical

invested in

Duomed Group

in 2024

in a Strategic Partnership deal

Disclosed details

Revenue: $660M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert